Elevated Preoperative Serum Vascular Endothelial Growth Factor Does Not Predict Poor Outcomes in Curatively Resected Non-metastatic Colorectal Cancer Treated …

N Nakai, A Maeda, T Yanagita, T Suzuki… - Anticancer …, 2023 - ar.iiarjournals.org
Background/Aim: Vascular endothelial growth factor (VEGF) influences colorectal cancer
(CRC) progression and is a key target in the treatment for metastatic CRC. However, the …

Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer

KF Chin, J Greenman, E Gardiner, H Kumar… - British Journal of …, 2000 - nature.com
We aim to determine the clinical usefulness of pre-operative serum vascular endothelial
growth factor (VEGF) as a predictor of outcome in patients undergoing curative resection for …

Preoperative vascular endothelial growth factor levels as a prognostic marker for stage II or III colorectal cancer patients

O Kemik, AS Kemik, A Sümer, S Purisa… - Cancer Growth and …, 2011 - journals.sagepub.com
Background The aim of the present study was to determine whether serum vascular
endothelial growth factor (VEGF) can provide prognostic information independent of …

[HTML][HTML] Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer

KA Kwon, SH Kim, SY Oh, S Lee, JY Han, KH Kim… - BMC cancer, 2010 - Springer
Background Angiogenesis is a multistep process in which many growth factors and
cytokines have an essential role. Vascular endothelial growth factor (VEGF) is a potent …

Postoperative serum Vascular Endothelial Growth Factor is an independent prognostic factor of disease free survival and overall survival in patients with non …

M Pascual, S Alonso, S Salvans, X Mayol… - The American Journal of …, 2018 - Elsevier
Background Angiogenesis is essential for tumor growth and formation of metastasis. VEGF
is the most potent agiogenic citokine. The aim was to investigate the predictive value of …

Circulating vascular endothelial growth factor six months after primary surgery as a prognostic marker in patients with colorectal cancer

K Werther, S Sĝrensen, IJ Christensen… - Acta …, 2003 - Taylor & Francis
High preoperative circulating vascular endothelial growth factor (VEGF) is predictive of poor
prognosis in patients with colorectal cancer (CRC). However, postoperative circulating …

Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma

F De Vita, M Orditura, E Lieto, S Infusino, F Morgillo… - Cancer, 2004 - Wiley Online Library
BACKGROUND To the authors' knowledge, little is known to date regarding the prognostic
relevance of measuring serum levels of vascular endothelial growth factor (VEGF), a potent …

Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection

HL Tsai, IP Yang, CH Lin, CY Chai, YH Huang… - International journal of …, 2013 - Springer
Background Preclinical and clinical studies have indicated that vascular endothelial growth
factor (VEGF) is the predominant angiogenic factor. Recently, there was a consistent trend of …

[HTML][HTML] Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma

K Werther, IJ Christensen, HJ Nielsen - British journal of cancer, 2002 - nature.com
In serum, the major part of vascular endothelial growth factor derives from in vitro
degranulation of granulocytes and platelets. Therefore, plasma may be preferred for …

Clinical significance of preoperative serum vascular endothelial growth factor levels in patients with colorectal cancer and the effect of tumor surgery

AJ Karayiannakis, KN Syrigos, A Zbar, N Baibas… - Surgery, 2002 - Elsevier
Background. Vascular endothelial growth factor (VEGF) is an angiogenic cytokine involved
in the progression of solid tumors. In this study we evaluated the clinical usefulness of …